Toronto Dominion Bank Portfolio holdings
AUM
$46.6B
1-Year Return
18.57%
This Quarter Return
-2.13%
1 Year Return
+18.57%
3 Year Return
+57.01%
5 Year Return
+108.65%
10 Year Return
+217.35%
AUM
$39.1B
AUM Growth
-$12.6B
(-24%)
Cap. Flow
-$12.2B
Cap. Flow
% of AUM
-31.09%
Top 10 Holdings %
Top 10 Hldgs %
33.29%
Holding
1,334
New
142
Increased
406
Reduced
472
Closed
170
Top Buys
| 1 |
Canadian Natural Resources
CNQ
|
+$520M |
| 2 |
TC Energy
TRP
|
+$501M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$456M |
| 4 |
Scotiabank
BNS
|
+$421M |
| 5 |
Royal Bank of Canada
RY
|
+$283M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$14.5B |
| 2 |
Coinbase
COIN
|
+$164M |
| 3 |
Apple
AAPL
|
+$158M |
| 4 |
UnitedHealth
UNH
|
+$135M |
| 5 |
Toronto Dominion Bank
TD
|
+$133M |
Sector Composition
| 1 | Financials | 25.76% |
| 2 | Technology | 22.26% |
| 3 | Energy | 11.1% |
| 4 | Consumer Discretionary | 8.15% |
| 5 | Communication Services | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
LPL Financial
LPLA
$28.1B
| $3.68M | 0.01% |
11,262
+1,488
| +15% | +$487K |
|
602
Carvana
CVNA
$50B
| $3.68M | 0.01% |
17,582
+2,221
| +14% | +$464K |
|
603
Viatris
VTRS
$11.6B
| $3.66M | 0.01% |
419,715
-227,159
| -35% | -$1.98M |
|
604
Mohawk Industries
MHK
$8.45B
| $3.65M | 0.01% |
31,966
+10,969
| +52% | +$1.25M |
|
605
Pinduoduo
PDD
$178B
| $3.64M | 0.01% |
30,737
+10,801
| +54% | +$1.28M |
|
606
Humacyte
HUMA
$233M
| $3.63M | 0.01% |
+2,131,390
| New | +$3.63M |
|
|
DTSQ
607
DT Cloud Star Acquisition Corporation Ordinary Shares
DTSQ
$93.2M
| $3.61M | 0.01% |
351,740
-105,315
| -23% | -$1.08M |
|
608
Markel Group
MKL
$24.7B
| $3.59M | 0.01% |
1,921
+189
| +11% | +$353K |
|
609
Eastman Chemical
EMN
$7.71B
| $3.57M | 0.01% |
40,473
-21,664
| -35% | -$1.91M |
|
|
CLBR
610
DELISTED
Colombier Acquisition Corp II
CLBR
| $3.56M | 0.01% |
334,439
+272,439
| +439% | +$2.9M |
|
611
Apellis Pharmaceuticals
APLS
$3.14B
| $3.55M | 0.01% |
162,190
-834,863
| -84% | -$18.3M |
|
612
Moderna
MRNA
$9.15B
| $3.54M | 0.01% |
124,926
-49,094
| -28% | -$1.39M |
|
|
LEGT
613
Legato Merger Corp III
LEGT
$278M
| $3.5M | 0.01% |
333,234
+59,612
| +22% | +$625K |
|
|
DRDB
614
Roman DBDR Acquisition Corp. II Ordinary shares
DRDB
| $3.48M | 0.01% |
+346,475
| New | +$3.48M |
|
615
Boston Properties
BXP
$12.2B
| $3.47M | 0.01% |
51,685
+2,041
| +4% | +$137K |
|
|
DMAA
616
Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA
$345M
| $3.47M | 0.01% |
+2,210,100
| New | +$3.47M |
|
617
Incyte
INCY
$16.2B
| $3.44M | 0.01% |
56,762
-57,074
| -50% | -$3.46M |
|
|
FGMC
618
FG Merger II Corp. Common stock
FGMC
$103M
| $3.41M | 0.01% |
+821,918
| New | +$3.41M |
|
619
Brookfield Infrastructure
BIPC
$4.76B
| $3.38M | 0.01% |
93,599
-5,608
| -6% | -$203K |
|
620
Pan American Silver
PAAS
$15.5B
| $3.34M | 0.01% |
129,442
-7,418
| -5% | -$192K |
|
621
Carlisle Companies
CSL
$15.6B
| $3.34M | 0.01% |
9,811
+447
| +5% | +$152K |
|
622
Bio-Techne
TECH
$7.97B
| $3.26M | 0.01% |
55,579
-29,431
| -35% | -$1.73M |
|
623
Omnicell
OMCL
$1.46B
| $3.26M | 0.01% |
93,188
+7,611
| +9% | +$266K |
|
|
LPBB
624
Launch Two Acquisition Corp. Class A Ordinary Shares
LPBB
| $3.24M | 0.01% |
320,300
-68,700
| -18% | -$695K |
|
625
Exagen
XGN
$214M
| $3.2M | 0.01% |
891,366
| – | – |
|